BIOLOGIC RESPONSE-MODIFYING AGENTS - WHAT IS AN APPROPRIATE PHASE-I-II STRATEGY

被引：0
|
作者：
CARTER, SK
机构：
[1] STANFORD UNIV,STANFORD,CA 94305
[2] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 1980年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：207 / 210
页数：4
相关论文
共 50 条
  • [31] PHASE-I-II STUDY OF ACLACINOMYCIN FOR A TREATMENT OF ACUTE MYELOID-LEUKEMIA
    MACHOVER, D
    GASTIABURU, J
    DELGADO, M
    GOLDSCHMIDT, E
    HULHOVEN, R
    MISSET, JL
    DEVASSAL, F
    TAPIERO, H
    DORVAL, T
    RIBAUD, P
    SCHWARZENBERG, L
    MATHE, G
    BIOMEDICINE & PHARMACOTHERAPY, 1984, 38 (07) : 328 - 331
  • [32] PHASE-I-II STUDY OF ACLARUBICIN FOR TREATMENT OF ACUTE MYELOID-LEUKEMIA
    MACHOVER, D
    GASTIABURU, J
    DELGADO, M
    GOLDSCHMIDT, E
    HULHOVEN, R
    MISSET, JL
    DEVASSAL, F
    TAPIERO, H
    RIBAUD, P
    SCHWARZENBERG, L
    MATHE, G
    CANCER TREATMENT REPORTS, 1984, 68 (06): : 881 - 886
  • [33] PHASE-I-II TRIAL OF PULSE VINCRISTINE, ACTINOMYCIN-D AND CYCLOPHOSPHAMIDE
    GREEN, DM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 324 - 324
  • [34] PHASE-I-II TRIAL OF AN UNCONVENTIONAL AGENT, POLYERGA, IN PATIENTS WITH ADVANCED CANCER
    CHIAROTTO, J
    THIRLWELL, M
    TRUDEAU, M
    SKELTON, J
    BOOS, G
    VIALLET, J
    CLINICAL RESEARCH, 1994, 42 (01): : A104 - A104
  • [35] PHASE-I-II TRIAL OF ANTHRACENEDICARBOXALDEHYDE IN PATIENTS WITH REFRACTORY ADULT ACUTE-LEUKEMIA
    GERAD, H
    VANECHO, DA
    DONEHOWER, M
    POCELINKO, R
    WIERNIK, PH
    CANCER TREATMENT REPORTS, 1984, 68 (03): : 535 - 537
  • [36] PHASE-I-II STUDY OF PIPERAZINEDIONE IN ADULTS WITH SOLID TUMORS AND ACUTE-LEUKEMIA
    BENJAMIN, RS
    KEATING, MJ
    VALDIVIESO, M
    MCCREDIE, KB
    LIVINGSTON, RA
    BURGESS, MA
    RODRIGUEZ, V
    BODEY, GP
    GOTTLIEB, JA
    CANCER TREATMENT REPORTS, 1979, 63 (06): : 939 - 943
  • [37] PHASE-I-II CLINICAL-TRIAL OF GALLIUM NITRATE (NSC-15200)
    SAMSON, MK
    FRAILE, RJ
    BAKER, LH
    OBRYAN, R
    CANCER CLINICAL TRIALS, 1980, 3 (02) : 131 - 136
  • [38] PHASE-I-II CLINICAL STUDIES WITH IV AND ORAL FTORAFUR, A PRELIMINARY-REPORT
    ANSFIELD, FJ
    KALLAS, G
    SINGSON, J
    UY, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 349 - 349
  • [39] PHASE-I-II TRIAL OF MITOXANTRONE IN ACUTE-LEUKEMIA - AN INTERIM-REPORT
    ARLIN, ZA
    DUKART, G
    SCHOCH, I
    REISMAN, A
    MOORE, J
    SILVER, RA
    CASSILETH, P
    BERTINO, J
    GAMS, R
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (02) : 213 - 217
  • [40] 5-FLUOROURACIL AND FOLINIC ACID - A PHASE-I-II TRIAL IN GASTROINTESTINAL MALIGNANCY
    CUNNINGHAM, J
    BUKOWSKI, RM
    BUDD, GT
    WEICK, JK
    PURVIS, J
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (04) : 391 - 395
12345